Page last updated: 2024-10-25

deferiprone and Tricuspid Incompetence

deferiprone has been researched along with Tricuspid Incompetence in 1 studies

Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.

Research Excerpts

ExcerptRelevanceReference
"Deferiprone (L1) was found to have greater efficacy at depleting myocardial iron than desferrioxamine (DFX)."5.32Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with beta-thalassemia major. ( Chang, JS; Peng, CT; Tsai, CH; Wu, KH, 2004)
"Deferiprone (L1) was found to have greater efficacy at depleting myocardial iron than desferrioxamine (DFX)."1.32Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with beta-thalassemia major. ( Chang, JS; Peng, CT; Tsai, CH; Wu, KH, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wu, KH1
Chang, JS1
Tsai, CH1
Peng, CT1

Other Studies

1 other study available for deferiprone and Tricuspid Incompetence

ArticleYear
Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with beta-thalassemia major.
    Annals of hematology, 2004, Volume: 83, Issue:7

    Topics: Adult; beta-Thalassemia; Cardiovascular Agents; Deferiprone; Deferoxamine; Diabetes Complications; D

2004